Private label OTC drug manufacturers seek more time to comply with proposed regs.
This article was originally published in The Rose Sheet
Executive Summary
OTC LABEL REG: PRIVATE LABELERS SEEK MORE TIME TO COMPLY with FDA's proposed revisions to the over-the-counter drug labels, the Private Label Manufacturers Association stated at an agency "feedback" meeting in Rockville, Md. Sept. 30. PLMA, which represents over 2,500 retailers, manufacturers and distributors of store brand products, likely will ask FDA for an additional year or two to come into compliance with the OTC drug product labeling reg. The Feb. 27 final rule revising OTC drug labeling, expected in a year, will take effect two years after issuance.